The goal of this type of study is clinical trial. This to learn about effects of applied aerobic Thai dance exercise on gait balance and sudomotor function in patient with diabetic peripheral neuropathy. Test variables of gait, balance, function of sudomotor, Physiological data such as pulse, blood pressure, body composition, ankle and leg muscle strength, compare with control and experimental group in diabetes with peripheral neuropathy. The main question Question 1: Dose Applied aerobic Thai dance exercise affects gait and balance in diabetic patients with peripheral neuropathy? Question 2: Does applied aerobic Thai dance exercise affect sudomotor function in diabetic patients with peripheral neuropathy? Participants will divided into 2 groups: the control group and the experimental group. By randomly sampling 22 people from each group 1. The control group was advised to exercise at home for a period of 12 weeks. 2. The experimental group participated in Applied aerobic Thai dance exercise 60 minutes per session, 3 times per week, for a period of 12 weeks. After 12 weeks, variable data were collected and to compare within and between groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
44
Aerobic Thai dance exercise 60 minute per times, 3 times per weeks of 12 weeks. Aerobic exercise of modulate intensity (12-13 Borg's RPE)
Chulalongkorn university
Bangkok, Thailand
Gait Speed
Gait Speed will be measured by Strideway in centimeter per seconds (cm/sec).
Time frame: Baseline and 12 weeks
Step length
Step length will be measured by Strideway in centimeter (cm).
Time frame: Baseline and 12 weeks
Single Support
Single Support will be measured by Strideway in seconds (sec).
Time frame: Baseline and 12 weeks
Double Support
Double Support will be measured by Strideway in seconds (sec).
Time frame: Baseline and 12 weeks
Cadence
Cadence will be measured by Strideway in steps per minute (steps/minute).
Time frame: Baseline and 12 weeks
Postural Stability Testing
Postural Stability Testing will be measured by Biodex balance system in score.
Time frame: Baseline and 12 weeks
Modified Clinical Test of Sensory Interaction in Balance (M-CTSIB)
Modified Clinical Test of Sensory Interaction in Balance (M-CTSIB) will be measured by Biodex balance system in score.
Time frame: Baseline and 12 weeks
Limits of Stability (LOS)
Limits of Stability (LOS) will be measured by Biodex balance system in score.
Time frame: Baseline and 12 weeks
Time up and go test
Functional balance test will be measured by Time up and go test in seconds.
Time frame: Baseline and 12 weeks
Functional reach test
Functional balance test will be measured by Functional reach test in centimeter.
Time frame: Baseline and 12 weeks
Sudomotor function
Sudomotor function testing feet and hands will be measured by Sudoscan in microsiemens (µS).
Time frame: Baseline and 12 weeks
Leg muscle strength
Leg muscle strength testing will be measured by Isokinetic dynamometer in newton meter (Nm).
Time frame: Baseline and 12 weeks
Ankle muscle strength
Ankle Muscle strength testing will be measured by Hand-held dynamometry in kilogram (Kg).
Time frame: Baseline and 12 weeks
Michigan Neuropathy Screening Instrument (MNSI)
Questionnaire variables will be measured by Michigan Neuropathy Screening Instrument (MNSI) in score. The scale's range in score is from 0 to 13. Cut off greater than or equal to 2 scores and a low score represents mild neuropathy, whereas a high score represents severe neuropathy.
Time frame: Baseline and 12 weeks
Short-form McGill Pain Questionnaire (SF-MPQ)
Questionnaire variables will be measured by Short-form McGill Pain Questionnaire (SF-MPQ) in score. The scale's range in score is from 0 to 60. A low score represents no pain, whereas a high score represents worse pain.
Time frame: Baseline and 12 weeks
Neurological symptom score (NSS)
Questionnaire variables will be measured by Neurological symptom score (NSS) in score. The scale's range in score is from 0 to 18. A low score represents mild neuropathic symptoms, whereas a high score represents severe neuropathic symptoms.
Time frame: Baseline and 12 weeks
Foot Pain Manikin
Questionnaire variables will be measured by Foot Pain Manikin in score. The scale's range in score is from 0 to 50. A low score represents no area of pain, whereas a high score represents a wide area of pain.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline and 12 weeks
Falls Efficacy Scale International (FES-I)
Questionnaire variables will be measured by Falls Efficacy Scale International (FES-I) in score. The scale's range in score is from 16 to 64. A low score represents no concern about falling, whereas a high score represents severe concern about falling.
Time frame: Baseline and 12 weeks
Fasting Plasma Glucose (FPG)
Fasting Plasma Glucose (FPG) will be measured by medical technician in faculty of Allied Health Sciences Chulalongkorn University in milligrams per deciliter (mg/dL).
Time frame: Baseline and 12 weeks
Hemoglobin A1c (HbA1C)
Hemoglobin A1c (HbA1C) will be measured by medical technician in faculty of Allied Health Sciences Chulalongkorn University in percentage.
Time frame: Baseline and 12 weeks
High Density Lipoprotein (HDL)
High Density Lipoprotein (HDL) will be measured by medical technician in faculty of Allied Health Sciences Chulalongkorn University in milligrams per deciliter (mg/dL).
Time frame: Baseline and 12 weeks
Low Density Lipoprotein (LDL)
Low Density Lipoprotein (LDL) will be measured by medical technician in faculty of Allied Health Sciences Chulalongkorn University in milligrams per deciliter (mg/dL).
Time frame: Baseline and 12 weeks
Blood pressure
Blood pressure will be measured by Sphygmomanometer in mmHg.
Time frame: Baseline and 12 weeks
Resting heart rate
Resting heart rate will be measured by Sphygmomanometer in Times per minute (Times/ minute).
Time frame: Baseline and 12 weeks
Weight
Weight will be measured by Body Composition Analyzer in kilogram (kg).
Time frame: Baseline and 12 weeks
Height
Height will be measured by Body Composition Analyzer in centimeter (cm).
Time frame: Baseline and 12 weeks
Body mass index (BMI)
Weight and height will be combined to report Body mass index (BMI) in kg/m\^2.
Time frame: Baseline and 12 weeks
Body fat
Body fat index will be measured by Dexa Scan in percentage.
Time frame: Baseline and 12 weeks
Muscle mass
Muscle mass index will be measured by Dexa Scan in kilogram (kg).
Time frame: Baseline and 12 weeks